83 FR 42656 - Meeting of the Advisory Committee on Immunization Practices

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention

Federal Register Volume 83, Issue 164 (August 23, 2018)

Page Range		42656-42656
FR Document		2018-18184

In accordance with the Federal Advisory Committee Act, the CDC announces the following meeting of the Advisory Committee on Immunization Practices (ACIP). This meeting is open to the public, limited only by room seating. The meeting room accommodates 400. Time will be available for public comment.

Federal Register, Volume 83 Issue 164 (Thursday, August 23, 2018)

[Federal Register Volume 83, Number 164 (Thursday, August 23, 2018)]
[Notices]
[Page 42656]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2018-18184]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Meeting of the Advisory Committee on Immunization Practices

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: In accordance with the Federal Advisory Committee Act, the CDC 
announces the following meeting of the Advisory Committee on 
Immunization Practices (ACIP). This meeting is open to the public, 
limited only by room seating. The meeting room accommodates 400. Time 
will be available for public comment.

DATES: The meeting will be held on October 24, 2018, 8:30 a.m. to 5:15 
p.m., EDT, and October 25, 2018, 8:30 a.m. to 4:00 p.m. EDT.
    The public is welcome to submit written comments in advance of the 
meeting. Comments should be submitted in writing by email to the 
contact person listed in FOR FURTHER INFORMATION CONTACT. The deadline 
for receipt is October 15, 2018.

ADDRESSES: CDC, 1600 Clifton Road NE, Tom Harkin Global Communications 
Center, Kent `Oz' Nelson Auditorium, Atlanta, GA 30329-4027.
    The meeting will be webcast live via the World Wide Web; for 
instructions and more information on ACIP please visit the ACIP 
website: http://www.cdc.gov/vaccines/acip/index.html.

FOR FURTHER INFORMATION CONTACT: Stephanie Thomas, ACIP Committee 
Management Specialist, CDC, NCIRD, telephone 404-639-8836, email 
[email protected].

SUPPLEMENTARY INFORMATION:
    Purpose: The committee is charged with advising the Director, CDC, 
on the use of immunizing agents. In addition, under 42 U.S.C. 1396s, 
the committee is mandated to establish and periodically review and, as 
appropriate, revise the list of vaccines for administration to vaccine-
eligible children through the Vaccines for Children (VFC) program, 
along with schedules regarding dosing interval, dosage, and 
contraindications to administration of vaccines. Further, under 
provisions of the Affordable Care Act, section 2713 of the Public 
Health Service Act, immunization recommendations of the ACIP that have 
been approved by the Director of the Centers for Disease Control and 
Prevention and appear on CDC immunization schedules must be covered by 
applicable health plans.
    Matters to Be Considered: The agenda will include discussions on 
child/adolescent immunization schedule, adult immunization schedule, 
human papillomavirus vaccines, pneumococcal vaccines, Japanese 
encephalitis vaccines, zoster vaccine, Influenza vaccines, general 
recommendations, anthrax vaccine, hepatitis A vaccine, Pertussis 
vaccine, and meningococcal vaccines. A recommendation vote is scheduled 
for child/adolescent immunization schedule and adult immunization 
schedule. Agenda items are subject to change as priorities dictate. For 
more information on the meeting agenda visit https://www.cdc.gov/vaccines/acip/meetings/meetings-info.html.
    Public Comment: Written comments must include full name, address, 
organizational affiliation, email address of the speaker, topic being 
addressed and specific comments. Written comments must not exceed one 
single-spaced typed page with 1-inch margins containing all items 
above. Only those written comments received 10 business days in advance 
of the meeting will be included in the official record of the meeting. 
Public comments made in attendance must be no longer than 3 minutes and 
the person giving comments must attend the public comment session at 
the start time listed on the agenda. Time for public comments may start 
before the time indicated on the agenda. The Director, Management 
Analysis and Services Office, has been delegated the authority to sign 
Federal Register notices pertaining to announcements of meetings and 
other committee management activities, for both the Centers for Disease 
Control and Prevention and the Agency for Toxic Substances and Disease 
Registry.

Sherri Berger,
Chief Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2018-18184 Filed 8-22-18; 8:45 am]
 BILLING CODE 4163-18-P

42656 Federal Register / Vol. 83, No. 164 / Thursday, August 23, 2018 / Notices

would constitute a clearly unwarranted INFORMATION CONTACT. The deadline for meeting. Public comments made in
invasion of personal privacy. receipt is October 15, 2018. attendance must be no longer than 3
Name of Committee: Disease, ADDRESSES: CDC, 1600 Clifton Road NE, minutes and the person giving
Disability, and Injury Prevention and Tom Harkin Global Communications comments must attend the public
Control Special Emphasis Panel (SEP)— Center, Kent ‘Oz’ Nelson Auditorium, comment session at the start time listed
RFA–CE19–001, Injury Control Research Atlanta, GA 30329–4027. on the agenda. Time for public
Centers. The meeting will be webcast live via comments may start before the time
Dates: October 30, 2018 and the World Wide Web; for instructions indicated on the agenda. The Director,
November 2, 2018 and more information on ACIP please Management Analysis and Services
Time: 8:30 a.m.–5:00 p.m., EDT visit the ACIP website: http:// Office, has been delegated the authority
Place: The Georgian Terrace, 659 www.cdc.gov/vaccines/acip/index.html. to sign Federal Register notices
Peachtree St. NE, Atlanta, GA, 30308 FOR FURTHER INFORMATION CONTACT: pertaining to announcements of
Agenda: To review and evaluate grant Stephanie Thomas, ACIP Committee meetings and other committee
applications. Management Specialist, CDC, NCIRD, management activities, for both the
For Further Information Contact: Centers for Disease Control and
telephone 404–639–8836, email ACIP@
Mikel L. Walters, M.A., Ph.D., Scientific Prevention and the Agency for Toxic
cdc.gov.
Review Official, NCIPC, CDC, 4770 Substances and Disease Registry.
Buford Highway NE, Mailstop F–63, SUPPLEMENTARY INFORMATION:
Atlanta, Georgia 30341, Telephone: Purpose: The committee is charged Sherri Berger,
(404) 639–0913; Email: mwalters@ with advising the Director, CDC, on the Chief Operating Officer, Centers for Disease
cdc.gov. use of immunizing agents. In addition, Control and Prevention.
The Director, Management Analysis under 42 U.S.C. 1396s, the committee is [FR Doc. 2018–18184 Filed 8–22–18; 8:45 am]
and Services Office, has been delegated mandated to establish and periodically BILLING CODE 4163–18–P
the authority to sign Federal Register review and, as appropriate, revise the
notices pertaining to announcements of list of vaccines for administration to
meetings and other committee vaccine-eligible children through the DEPARTMENT OF HEALTH AND
management activities, for both the Vaccines for Children (VFC) program, HUMAN SERVICES
Centers for Disease Control and along with schedules regarding dosing
Prevention and the Agency for Toxic interval, dosage, and contraindications Centers for Disease Control and
Substances and Disease Registry. to administration of vaccines. Further, Prevention
under provisions of the Affordable Care
Sherri Berger, Act, section 2713 of the Public Health [60Day–18–18ATK; Docket No.CDC–2018–
Chief Operating Officer, Centers for Disease Service Act, immunization 0075]
Control and Prevention. recommendations of the ACIP that have
[FR Doc. 2018–18188 Filed 8–22–18; 8:45 am] Proposed Data Collection Submitted
been approved by the Director of the
for Public Comment and
BILLING CODE 4163–18–P Centers for Disease Control and
Recommendations
Prevention and appear on CDC
immunization schedules must be AGENCY: Centers for Disease Control and
DEPARTMENT OF HEALTH AND covered by applicable health plans. Prevention (CDC), Department of Health
HUMAN SERVICES Matters to Be Considered: The agenda and Human Services (HHS).
will include discussions on child/ ACTION: Notice with comment period.
Centers for Disease Control and adolescent immunization schedule,
Prevention adult immunization schedule, human SUMMARY: The Centers for Disease
Meeting of the Advisory Committee on papillomavirus vaccines, pneumococcal Control and Prevention (CDC), as part of
Immunization Practices vaccines, Japanese encephalitis its continuing effort to reduce public
vaccines, zoster vaccine, Influenza burden and maximize the utility of
AGENCY: Centers for Disease Control and vaccines, general recommendations, government information, invites the
Prevention (CDC), Department of Health anthrax vaccine, hepatitis A vaccine, general public and other Federal
and Human Services (HHS). Pertussis vaccine, and meningococcal agencies the opportunity to comment on
ACTION: Notice of meeting. vaccines. A recommendation vote is a proposed and/or continuing
scheduled for child/adolescent information collection, as required by
SUMMARY: In accordance with the immunization schedule and adult the Paperwork Reduction Act of 1995.
Federal Advisory Committee Act, the immunization schedule. Agenda items This notice invites comment on a
CDC announces the following meeting are subject to change as priorities proposed information collection project
of the Advisory Committee on dictate. For more information on the titled Understanding multi-sectoral
Immunization Practices (ACIP). This meeting agenda visit https:// collaboration for strengthening public
meeting is open to the public, limited www.cdc.gov/vaccines/acip/meetings/ health capacities in Ethiopia. The goal
only by room seating. The meeting room meetings-info.html. of this study is to explore multi-sectoral
accommodates 400. Time will be Public Comment: Written comments collaboration in Ethiopia, in the context
available for public comment. must include full name, address, of strengthening public health capacities
DATES: The meeting will be held on organizational affiliation, email address under the Global Health Security
October 24, 2018, 8:30 a.m. to 5:15 p.m., of the speaker, topic being addressed Agenda.
daltland on DSKBBV9HB2PROD with NOTICES

EDT, and October 25, 2018, 8:30 a.m. to and specific comments. Written
4:00 p.m. EDT. comments must not exceed one single- DATES:CDC must receive written
The public is welcome to submit spaced typed page with 1-inch margins comments on or before October 22,
written comments in advance of the containing all items above. Only those 2018.
meeting. Comments should be written comments received 10 business ADDRESSES: You may submit comments,
submitted in writing by email to the days in advance of the meeting will be identified by Docket No. CDC–2018–
contact person listed in FOR FURTHER included in the official record of the 0075 by any of the following methods:

VerDate Sep<11>2014 19:43 Aug 22, 2018 Jkt 244001 PO 00000 Frm 00021 Fmt 4703 Sfmt 4703 E:\FR\FM\23AUN1.SGM 23AUN1

Document Created: 2018-08-23 00:32:31
Document Modified: 2018-08-23 00:32:31

Category		Regulatory Information
Collection		Federal Register
sudoc Class		AE 2.7: GS 4.107: AE 2.106:
Publisher		Office of the Federal Register, National Archives and Records Administration
Section		Notices
Action		Notice of meeting.
Dates		The meeting will be held on October 24, 2018, 8:30 a.m. to 5:15 p.m., EDT, and October 25, 2018, 8:30 a.m. to 4:00 p.m. EDT.
Contact		Stephanie Thomas, ACIP Committee Management Specialist, CDC, NCIRD, telephone 404-639-8836, email [email protected]
FR Citation		83 FR 42656

83 FR 42656 - Meeting of the Advisory Committee on Immunization Practices

DEPARTMENT OF HEALTH AND HUMAN SERVICESCenters for Disease Control and Prevention

Federal Register Volume 83, Issue 164 (August 23, 2018)

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention